PharmTech
CONTINUE TO SITE >

OR WAIT 15 SECS

2009 Post-Interphex Showcase: Outsourcing & Consulting Services

April 7, 2009

2009 Post-Interphex Showcase: Outsourcing & Consulting Services

Contract services
Founded in 1994, QPharma has built its reputation on delivering value to the life-science and related industries through a wide range of regulatory and compliance solutions. QPharma’s suite of professional services spans the product-development life cycle, from quality and validation solutions to fulfillment services.

QPharma, Morristown, NJ
www.qpharmacorp.com
tel. 973.656.0011

Contract services
UPM Pharmaceuticals is a drug-development and contract-manufacturing company that provides formulation development, manufacturing, and analytical services. UPM’s scientists have industry experience in oral solid and liquid dosage forms from feasibility and Phases I–III to commercial products. The company’s services are characterized by responsiveness and timely communications and are customized to clients’ drug-development programs.

UPM Pharmaceuticals, Baltimore, MD
www.upm-inc.com
tel. 410.843.3700

Dual-chamber technology
Vetter offers a process for aseptically prefilled syringe systems. The process prefills different ingredients and solvents separately and stores them in a specially developed dual-chamber system. This procedure enables the lyophilization of substances that are unstable in liquid form. The dual-chamber system is easy for patients to use.

Vetter Pharma-Fertigung, Ravensburg, Germany
www.vetter-pharma.com
tel. +49 0 751 3700 0

Manufacturing services
Bayer has expanded its Pharmaceutical Manufacturing Services Program to better serve current and potential clients. The company’s multiuse plant is designed for flexibility and precision manufacturing of sterile injectables, nonsterile liquids, solid doses, creams, and pastes. The company meets regulatory requirements.

Bayer HealthCare, Shawnee, KS
www.BayerPharmaMFGServices.com
tel. 800.255.6517

Cytotoxic contract
manufacturing

An eight-page brochure describes Baxter’s cytotoxic manufacturing facility in Halle, Germany. It includes information about cytotoxic contract manufacturing using barrier-isolator technology and services such as lyophilization, liquid-vial filling, dry-powder filling, and sterile crystallization. The facility manufactures for distribution to markets such as the United States, Europe, and Japan.

Baxter BioPharma Solutions, Round Lake, IL
www.baxterbiopharmasolutions.com
tel. 800.422.9837

Sterile manufacturing
capabilities

Pfizer CentreSource offers various sterile manufacturing capabilities. The company manufactures sterile suspension solutions, lyophilized products, and cytotoxic products. Development and commercial-scale production are available. Other services include stability testing, scale-up, technology transfer, process optimization, and validation.

Pfizer CentreSource (PCS), Kalamazoo, MI
www.pfizercentresource.com
tel. 269.833.5844

Product-development services
Azopharma Product Development Group provides clients with comprehensive services from discovery through commercialization. The company maximizes communication and minimizes downtime by bundling services from key sections of the drug-development process. Azopharma offers stand-alone services and comprehensive programs to fit clients’ needs.

Azopharma Product Development Group, Hollywood, FL
www.azopdogroup.com
tel. 954.433.7480

Outsourcing services
Stiefel produces liquids and semisolids, including gels, creams, ointments, topical solutions, and liquid orals in prescription and over-the-counter formulations. The company manufactures batch sizes from 170 to 3300 kg. Its packaging capabilities include metal, plastic, and laminate tubes. Stiefel also packages tottles and glass and plastic bottles.

Stiefel Outsourcing Services, Oak Hill, NY
www.stiefel.com
tel. 518.261.8766